Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Aclaris, Ampio, Arch, Ascentage, Beigene, Bio-Thera, Curevac, Cynata, Edesa, Kyowa Kirin, Innovent, Kamada, Merck, Pear, PTC, Sanofi, Regeneron, Ultragenyx.